Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease

被引:60
|
作者
Ajmera, Veeral H. [1 ,2 ]
Liu, Amy [1 ]
Singh, Seema [1 ]
Yachoa, Georg [1 ]
Ramey, Matthew [1 ]
Bhargava, Meera [1 ]
Zamani, Ava [1 ]
Lopez, Scarlett [1 ]
Mangla, Neeraj [1 ]
Bettencourt, Ricki [1 ]
Rizo, Emily [1 ]
Valasek, Mark [3 ]
Behling, Cynthia [4 ]
Richards, Lisa [1 ]
Sirlin, Claude [5 ]
Loomba, Rohit [1 ,2 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[4] Sharp Med Grp, Dept Pathol, San Diego, CA USA
[5] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
关键词
TRANSIENT ELASTOGRAPHY; NONINVASIVE DIAGNOSIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; WEIGHT-LOSS; NAFLD; STEATOHEPATITIS; ACCURATE; BIOPSY; MRI;
D O I
10.1002/hep.30974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Cross-sectional studies have shown that magnetic resonance elastography (MRE) is accurate in the noninvasive detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD). However, there are limited data on the longitudinal association between an increase in liver stiffness on MRE and fibrosis progression in NAFLD. Therefore, using a well-characterized prospective cohort of patients with biopsy-proven NAFLD, we aimed to examine the longitudinal association between a 15% increase in liver stiffness on MRE and fibrosis progression in NAFLD. Approach and Results This prospective cohort study included 102 patients (62.7% women) with biopsy-proven NAFLD who underwent contemporaneous MRE and liver biopsy at baseline followed by a repeat paired liver biopsy and MRE assessment. The primary outcome was odds of fibrosis progression by one or more stage as assessed by the Nonalcoholic Steatohepatitis Clinical Research Network histologic scoring system. The mean (+/- SD) of age and body mass index (BMI) were 52 (+/- 14) years and 32.6 (+/- 5.3) kg/m(2), respectively. The median time interval between the two paired assessments was 1.4 years (interquartile range 2.15 years). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 27, 36, 12, 17, and 10, respectively. In unadjusted analysis, a 15% increase in MRE was associated with increased odds of histologic fibrosis progression (odds ratio [OR], 3.56; 95% confidence interval [CI], 1.17-10.76; P = 0.0248). These findings remained clinically and statistically significant even after multivariable adjustment for age, sex, and BMI (adjusted OR, 3.36; 95% CI, 1.10-10.31; P = 0.0339). A 15% increase in MRE was the strongest predictor of progression to advanced fibrosis (OR, 4.90; 95% CI, 1.35-17.84; P = 0.0159). Conclusions A 15% increase in liver stiffness on MRE may be associated with histologic fibrosis progression and progression from early fibrosis to advanced fibrosis.
引用
收藏
页码:849 / 860
页数:12
相关论文
共 50 条
  • [1] Magnetic resonance elastography is useful as non-invasive diagnostic method for predicting liver fibrosis in nonalcoholic fatty liver disease
    Imajo, Kento
    Kessoku, Takaomi
    Honda, Yasushi
    Ogawa, Yuji
    Mawatari, Hironori
    Yoneda, Masato
    Saito, Satoru
    Nakajima, Atsushi
    HEPATOLOGY, 2014, 60 : 439A - 440A
  • [2] Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease
    Taouli, Bachir
    Serfaty, Lawrence
    GASTROENTEROLOGY, 2016, 150 (03) : 553 - 556
  • [3] Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease
    Inada, Kento
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Kirino, Sakura
    Yamashita, Koji
    Hayakawa, Yuka
    Higuchi, Mayu
    Takaura, Kenta
    Kaneko, Shun
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (09) : 1726 - 1731
  • [4] The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
    Idilman, Ilkay S.
    Karcaaltincaba, Musturay
    HEPATOLOGY FORUM, 2023, 4 (01): : 1 - 2
  • [5] Magnetic Resonance Elastography Measured Shear Stiffness as a Biomarker of Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease
    Schwimmer, Jeffrey B.
    Behling, Cynthia
    Angeles, Jorge Eduardo
    Paiz, Melissa
    Durelle, Janis
    Africa, Jonathan
    Newton, Kimberly P.
    Brunt, Elizabeth M.
    Lavine, Joel E.
    Abrams, Stephanie H.
    Masand, Prakash
    Krishnamurthy, Rajesh
    Wong, Kelvin
    Ehman, Richard L.
    Yin, Meng
    Glaser, Kevin J.
    Dzyubak, Bogdan
    Wolfson, Tanya
    Gamst, Anthony C.
    Hooker, Jonathan
    Haufe, William
    Schlein, Alexandra
    Hamilton, Gavin
    Middleton, Michael S.
    Sirlin, Claude B.
    HEPATOLOGY, 2017, 66 (05) : 1474 - 1485
  • [6] Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis
    Yali Qu
    Michael S. Middleton
    Rohit Loomba
    Kevin J. Glaser
    Jun Chen
    Jonathan C. Hooker
    Tanya Wolfson
    Yesenia Covarrubias
    Mark A. Valasek
    Kathryn J. Fowler
    Yingzhen N. Zhang
    Ethan Sy
    Anthony C. Gamst
    Kang Wang
    Adrija Mamidipalli
    Jeffrey B. Schwimmer
    Bin Song
    Scott B. Reeder
    Meng Yin
    Richard L. Ehman
    Claude B. Sirlin
    European Radiology, 2021, 31 : 8408 - 8419
  • [7] Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study
    Loomba, Rohit
    Wolfson, Tanya
    Ang, Brandon
    Hooker, Jonathan
    Behling, Cynthia
    Peterson, Michael
    Valasek, Mark
    Lin, Grace
    Brenner, David
    Gamst, Anthony
    Ehman, Richard
    Sirlin, Claude
    HEPATOLOGY, 2014, 60 (06) : 1920 - 1928
  • [8] Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis
    Qu, Yali
    Middleton, Michael S.
    Loomba, Rohit
    Glaser, Kevin J.
    Chen, Jun
    Hooker, Jonathan C.
    Wolfson, Tanya
    Covarrubias, Yesenia
    Valasek, Mark A.
    Fowler, Kathryn J.
    Zhang, Yingzhen N.
    Sy, Ethan
    Gamst, Anthony C.
    Wang, Kang
    Mamidipalli, Adrija
    Schwimmer, Jeffrey B.
    Song, Bin
    Reeder, Scott B.
    Yin, Meng
    Ehman, Richard L.
    Sirlin, Claude B.
    EUROPEAN RADIOLOGY, 2021, 31 (11) : 8408 - 8419
  • [9] Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease
    Ajmera, Veeral
    Nguyen, Khang
    Tamaki, Nobuharu
    Sharpton, Suzanne
    Bettencourt, Ricki
    Loomba, Rohit
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [10] Obesity predicts discordancy between magnetic resonance elastography and transient elastography for the stage of fibrosis in patients with nonalcoholic fatty liver disease
    Caussy, Cyrielle
    Chen, Jun
    Alquraish, Mosab
    Cepin, Sandra
    Nguyen, Phirum
    Hernandez, Carolyn
    Yin, Meng
    Bettencourt, Ricki
    Cachay, Edward R.
    Jayakumar, Saumya
    Fortney, Lynda
    Hooker, Jonathan
    Sy, Ethan Z.
    Valasek, Mark A.
    Rizo, Emily
    Richards, Lisa M.
    Brenner, David A.
    Sirlin, Claude B.
    Ehman, Richard
    Loomba, Rohit
    HEPATOLOGY, 2017, 66 : 335A - 335A